Statement Of Cash Flows

JCR Pharmaceuticals Co.,Ltd. - Filing #7295903

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
325,000,000 JPY
1,278,000,000 JPY
Interest and dividends received
85,000,000 JPY
55,000,000 JPY
Interest paid
-68,000,000 JPY
-40,000,000 JPY
Net cash provided by (used in) operating activities
-1,109,000,000 JPY
3,521,000,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Cash flows from investing activities
Purchase of property, plant and equipment
-2,992,000,000 JPY
-838,000,000 JPY
Net cash provided by (used in) investing activities
-2,962,000,000 JPY
-1,288,000,000 JPY
Other, net
30,000,000 JPY
-449,000,000 JPY
Cash flows from facilities maintenance and investing activities
Cash flows from financing activities
Proceeds from long-term borrowings
300,000,000 JPY
8,650,000,000 JPY
Dividends paid
-1,248,000,000 JPY
-1,249,000,000 JPY
Repayments of long-term borrowings
-300,000,000 JPY
-750,000,000 JPY
Redemption of bonds
JPY
-500,000,000 JPY
Net cash provided by (used in) financing activities
3,852,000,000 JPY
-761,000,000 JPY
Other, net
-26,000,000 JPY
-22,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-264,000,000 JPY
1,217,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-484,000,000 JPY
2,689,000,000 JPY
Cash and cash equivalents
18,271,000,000 JPY
18,756,000,000 JPY
15,968,000,000 JPY
13,278,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.